We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

838 hedge funds and large institutions have $25.5B invested in Edwards Lifesciences in 2018 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 286 increasing their positions, 314 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 54

11% more call options, than puts

Call options by funds: $152M | Put options by funds: $136M

5% more funds holding in top 10

Funds holding in top 10: 21 → 22 (+1)

3% more funds holding

Funds holding: 815 → 838 (+23)

5% more capital invested

Capital invested by funds: $24.3B → $25.5B (+$1.16B)

0.55% more ownership

Funds ownership: 249.42% → 249.97% (+0.55%)

9% less repeat investments, than reductions

Existing positions increased: 286 | Existing positions reduced: 314

Holders
838
Holders Change
+23
Holders Change %
+2.82%
% of All Funds
19.18%
Holding in Top 10
22
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.76%
% of All Funds
0.5%
New
82
Increased
286
Reduced
314
Closed
54
Calls
$152M
Puts
$136M
Net Calls
+$15.6M
Net Calls Change
-$6.4M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$233M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$187M
3
TCIM
TIAA CREF Investment Management
New York
+$109M
4
WCM Investment Management
WCM Investment Management
California
+$63.4M
5
Invesco
Invesco
Georgia
+$57M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$88.9M
2
Ameriprise
Ameriprise
Minnesota
-$80.6M
3
Renaissance Technologies
Renaissance Technologies
New York
-$71.7M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$71.7M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$70.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.12B +$22.9M +491,241 +0.8%
BlackRock
2
BlackRock
New York
$2.25B -$23.6M -505,983 -1%
State Street
3
State Street
Massachusetts
$1.2B -$19.2M -411,204 -2%
Bank of New York Mellon
4
Bank of New York Mellon
New York
$1.09B -$70.9M -1,519,842 -6%
Sands Capital Management
5
Sands Capital Management
Virginia
$1.01B +$55.3M +1,185,804 +6%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$977M +$233M +4,990,533 +33%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$923M +$11.8M +252,222 +1%
AllianceBernstein
8
AllianceBernstein
Tennessee
$700M -$20.5M -439,992 -3%
Brown Advisory
9
Brown Advisory
Maryland
$563M +$29.6M +633,774 +6%
Norges Bank
10
Norges Bank
Norway
$492M +$6.69M +143,304 +1%
TCIM
11
TIAA CREF Investment Management
New York
$483M +$109M +2,325,366 +31%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$387M +$15M +320,820 +4%
American Century Companies
13
American Century Companies
Missouri
$355M -$49.6M -1,061,643 -13%
Bank of America
14
Bank of America
North Carolina
$350M -$18.8M -402,189 -5%
Northern Trust
15
Northern Trust
Illinois
$347M +$80K +1,713 +0%
Ameriprise
16
Ameriprise
Minnesota
$340M -$80.6M -1,726,065 -20%
Massachusetts Financial Services
17
Massachusetts Financial Services
Massachusetts
$313M +$15.1M +323,028 +5%
Franklin Resources
18
Franklin Resources
California
$297M +$66.1K +1,416 +0%
DGI
19
Disciplined Growth Investors
Minnesota
$295M -$3.98M -85,344 -1%
Goldman Sachs
20
Goldman Sachs
New York
$269M -$88.9M -1,904,586 -26%
Wells Fargo
21
Wells Fargo
California
$263M -$60.5M -1,296,516 -19%
Artisan Partners
22
Artisan Partners
Wisconsin
$259M -$15.5M -333,060 -6%
Winslow Capital Management
23
Winslow Capital Management
Minnesota
$243M -$45.7M -979,323 -16%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$219M -$6.79M -145,563 -3%
Capital Research Global Investors
25
Capital Research Global Investors
California
$195M +$187M +4,016,181 New
1
2 3 4 5

EW Hedge Fund Activity: Q2 2018 in Review

838 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2018, worth a combined $25.5B — up 4.8% from $24.3B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new EW positions and 54 closed out — a net gain of 28 holders — while 286 added to existing stakes and 314 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $233M. The largest seller was Goldman Sachs, cutting an estimated $88.9M.

  • 838 institutional investors held Edwards Lifesciences (EW) as of Q2 2018, up from 815 in Q1 2018.
  • Funds reported $25.5B of Edwards Lifesciences stock for Q2 2018, up 4.8% quarter-over-quarter.
  • 82 funds opened new Edwards Lifesciences positions in Q2 2018 and 54 closed out, a net change of +28 holders.
  • The largest Edwards Lifesciences buyer in Q2 2018 was Fidelity Investments, an estimated $233M added.
  • The largest Edwards Lifesciences seller in Q2 2018 was Goldman Sachs, an estimated $88.9M sold.

Based on aggregated 13F filings for Q2 2018.